Look for markets that understand your products, also markets that are willing to give marketing support of biotechnology & pharmaceutical opportunities.
We mentioned earlier about finding markets that have favourable valuations towards biotechnology & pharmaceutical companies; let us look at some other factors:
‘¢ Do investment fund managers in these markets invest in biotechnology & healthcare companies?
‘¢ Are there specialist investor relations firms providing research reports and follow up on biotechnology & healthcare sectors?
‘¢ Does biotechnology sector represent a major sector in their asset allocation?
‘¢ Are there numerous biotechnology investment newsletters in these markets and what about their subscription rate?
By using this process, you can determine if you have chosen the right market to list your biotechnology company, and if this is a good base for you to build up your future investors database.
In States like California, Washington, Florida, Massachusetts where there are a lot of biotechnology headquarters in comparison to manufacturing or automotives industry States ‘” you can see there are always dedicated biotechnology research teams from stockbroking firms and fund managers.
In Canada, biotechnology related investment funds seem to be focused in Toronto and Quebec than Vancouver (where it is more IT and commercial services based), and this also makes them ideal locations for biotechnology start-up companies.
Similarly, in Asia, when we compare number of biotechnology newsletters available on market, there are numerous biotechnology investment funds and investment newsletters established in Hong Kong, Taiwan and Singapore; it seems that investors in those markets have more appetite for biotechnology opportunities than Australia & New Zealand, for Australia, medical devices companies are better received than pharmaceutical companies.
Japan is another market not to be missed by any biotechnology opportunities, not only they have number of specialist investment funds that only invest in biotechnology sectors, many corporations also have specific R&D divisions supporting new innovative opportunities.
By using the similar methodology, we also rank UK, Germany, France and Switzerland as major destinations for biotechnology start-ups based on the number of “biotechnology investment funds” and biotechnology investment investor relations & newsletters available.